Volume dodolan perusahaan Sera Prognostics (SERA)

Sera Prognostics is optimizing resources by outsourcing its manufacturing and clinic operations to third-party contractors. The company's sales trends confirm the effectiveness of this model, where the 0.00 mark reflects the latest data. This leader in predictive diagnostics helps physicians reduce the risks of premature birth, and the business is currently scaling the integration of its tests into US insurance standards.

Pendapatan lan volume dodolan Sera Prognostics, Inc. (SERA): kanggo periode 04.07.2022 - 13.11.2026

Rincian metrik komprehensif lan analitis Sera Prognostics, Inc. (SERA)

- rega pasar lan target rega analis:

Rega bursa seraprognostics.com|SERA - Bagan rega target

- rincian kapitalisasi pasar:

Kapitalisasi pasar Sera Prognostics, Inc.|SERA - Nilai Total Perusahaan

- statistik nilai buku emiten:

Aset Bersih saben Saham Sera Prognostics|SERA - Kapitalisasi Buku|Koefisien Nilai Pasar marang Nilai Buku seraprognostics.com|SERA - Aset Agregat Perusahaan

- data liabilitas lan likuiditas perusahaan:

Rasio Kabeh Utang marang Dana Pribadi Sera Prognostics|SERA - Utang jangka dawa marang modal|Utang jangka cendhak marang modal Sera Prognostics Inc.|SERA - Gunggung utang perusahaan|Rasio utang marang aset resik Sera Prognostics, Inc.|SERA - Utang jangka dawa perusahaan|Kewajiban jangka cendhak Sera Prognostics|Rasio jangkoan perantara seraprognostics.com

- rincian bathi lan kelipatan pasar:

SERA - Bathi resik perusahaan|Bathi resik sing dikarepake Sera Prognostics|SERA - Pangali P/E|Pangali forward rega marang bathi seraprognostics.com|SERA - Rasio rega marang bathi tumrap wutah|Nilai perusahaan marang bathi operasional sadurunge panyusutan Sera Prognostics, Inc.|SERA - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben siji saham sajrone rolas wulan pungkasan Sera Prognostics|SERA - Bathi saben saham sajrone rolas wulan pungkasan|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan seraprognostics.com|SERA - Wutah bathi resik saben saham ing taun iki|Proyeksi tambahing bathi saben saham ing taun ngarep Sera Prognostics

- statistik dodolan lan pendapatan perusahaan:

SERA - Pendapatan lan volume dodolan|Dodolan mangsa ngarep perusahaan Sera Prognostics Inc.|SERA - Multiplikator P/S|Multiplikator forward rega marang pendapatan Sera Prognostics, Inc.

Analisis umum perusahaan:seraprognostics.com - SERA

Investors assess fundamental capital risks through the dynamics of actual cash inflows. For Sera Prognostics (SERA), the commercialization of the PreTRM test and the expansion of insurance coverage serve as critical factors. By analyzing the company's trading revenue, the user compares daily shipment volumes with management's planned targets. This metric measures actual demand for diagnostics, filtering out market noise. Steady growth on the chart confirms the product's integration into government protocols.

Analisis perusahaan pesaing

Total pendapatan perusahaan Natera Medical NTRA|Pendapatan perusahaan Humacyte, Inc. (HUMA)